Share This Page Facebook Twitter Linked-In Tags: Health Care Prescription Drugs Manufacturing Pharmaceuticals Competition Merger Horizontal Bureau of Competition Date: May 5, 2020 Matter Number: 191 0169 By: Rebecca Kelly Slaughter, Acting Chair Dissenting Statement of Commissioner Rebecca Kelly Slaughter in the Matter of AbbVie and Allergan (405.02 KB)